Summary
- Board failures in fiduciary duty and oversight can doom companies by allowing misconduct, outdated skills, or misaligned composition to persist.
- Enron, Theranos, and FTX exemplify this risk that, ultimately, led to collapse of these firms and criminal convictions.
- The remedy is committed, ethical corporate governance, with independent, expert, and diverse boards that challenge management, manage risk, document rigorously, and plan continuously.
For organizations of every size, boards of directors are tasked with overseeing decisions that can lead to company success. Unfortunately, this means that directors who fail to follow through on their fiduciary duties and stay committed to the best interests of the business can also be responsible for a company’s downfall.
All directors need to understand the critical nature of the role they play in keeping a company on the right track.
Consider the following three board of directors failure examples:
These serve as cautionary tales, highlighing what can happen when boards don’t hold up their end of the bargain and send companies down a path to eventual destruction.
Enron
The Enron scandal continues to be one of the most well-known cautionary tales when it comes to business ethics. It’s an alarming story of what happens when executives engage in deliberate criminal behavior in an effort to feign business success — and boards don’t have the confidence to speak up.
On the surface, the Enron Corporation was seemingly one of America’s most successful energy companies. In reality, though, the company’s board and executives were using fraudulent accounting practices to hide the fact that they were in financial trouble.
Enron’s board knowingly employed what’s known as “mark-to-market” accounting to show estimated future profits as current earnings. Additionally, it used shell companies to hide the fact that the company was in massive debt.
These tactics allowed Enron’s executives and directors to inflate company profits in a way that grossly misled analysts and investors.
At the same time, Enron executives engaged in insider trading, selling company stock at inflated prices while they were well aware of the organization’s failing finances. Arthur Anderson, Enron’s accounting firm, was complicit in the scheme to boot, approving financial documents it knew to contain false information.
As one would predict, Enron eventually collapsed and filed for bankruptcy. Many employees lost their jobs, and investors saw stock prices plummet from $90 to just $1 per share, wiping out retirement savings for some. CEO Jefferey Skilling and CFO Andrew Fastow were tried and convicted for their roles in the fraudulent scheme.
Most importantly, the Enron board of directors’ failure led to the development and passing of the Sarbanes-Oxley Act (SOX) in 2002. This piece of regulation imposed stricter requirements for corporate governance, financial reporting, and auditor independence. It also set rules for harsher penalties for engaging in fraudulent behavior.
Theranos
Theranos was founded in 2003 by Elizabeth Holmes. At the time, Holmes was considered a business sensation. She was still a student at Stanford University when her company rose to prominence, prompting her to drop out of school to pursue the venture full-time.
Despite this inspirational beginning, the company’s story quickly took a dark twist.
Theranos’s main product, a device often referred to as the “Edison,” was supposed to streamline medical testing by performing a wide range of blood tests with a simple finger prick.
As investors would eventually find out, the machine’s capabilities were grossly overstated.
Unfortunately, the company began to unravel when inaccurate results led to misdiagnoses and harmful patient treatment. After a thorough investigation and trial, both Holmes and the company’s COO, Ramesh “Sunny” Balwani, were criminally charged and convicted of fraud, resulting in an 11-year prison sentence for Holmes.
While no board members were criminally charged in the investigation, the situation did raise eyebrows in regard to board composition and oversight. The Theranos board lacked directors with deep knowledge of the scientific and medical fields, which meant they were unable to reliably evaluate product claims and identify potential risks.
This also meant that the board was unable to faithfully challenge executives’ assertions, which led to them dismissing whistleblower claims and remaining silent about various issues. While no director faced jail time, their reputations and credibility were devastated, making it difficult for them to pursue other roles.
FTX
The FTX collapse of 2022 is one of the most glaring examples of board failure in recent times. The situation highlights what can happen when a board lacks structure and direction.
The company’s CEO, Sam Bankman-Fried, desired to take risks with the company and knew that significant board oversight would likely result in his being unable to do so.
Consequently, there was very little monitoring and control that would have caught the issues that led to the company’s eventual failure.
In addition to compromised integrity at the board level, there was a serious lack of transparency and accountability at FTX. The board didn’t include independent directors in its composition.
Instead, it was stacked with insiders who sought to profit from the firm’s activities rather than act in the best interests of the company.
Additionally, board members lacked expertise in the financial industry as well as business acumen, leading to inaccurate risk assessment and serious failures in risk management. Meeting minutes and other communications were routinely deleted, which made decision-making unclear.
The outcome in this case wouldn’t shock anyone: The poor board structure, coupled with the lack of oversight, disregard for compliance, and prioritization of growth over sound business decisions, eventually resulted in an ignominious end for FTX.
The company had begun using customer funds to engage in risky business behaviors. Over time, this led to a liquidity crisis. Ultimately, Bankman-Fried was arrested and charged with financial crimes, found guilty on all counts, and sentenced to 25 years in prison in late 2024.
Committed, Ethical Directors Are Critical to Business Longevity & Success
If you’re an ethical director or business owner, it’s likely that you can’t fathom engaging in the types of behaviors that led to these epic business failures. Even so, it’s important for board members to understand the grave importance of fulfilling their duties and maintaining integrity at every turn.
Whether it’s speaking up when you see something wrong, gaining additional skills needed for proper oversight, or just ensuring that you’re thoroughly prepared for meetings, your organization’s success depends on your willingness to stay committed to the requirements of your role.
When directors choose to do the right thing, all stakeholders are empowered to work together toward the best possible outcomes.
About Boardroom Pulse
Boardroom Pulse is the C-suite’s trusted source for forward-thinking, insightful coverage on corporate governance and the latest developments shaping today’s business world.
Our mission is simple yet ambitious: elevate boardroom governance standards and empower modern business leaders. To achieve this, we deliver comprehensive, timely news, in-depth analysis, and thought leadership that spark dialogue, highlight best practices, and promote responsible leadership in boardrooms and executive suites nationwide.
That’s why more executive directors, board members, CEOs, and senior leaders turn to Boardroom Pulse to navigate the complexities of the business landscape, strengthen the foundation for sustainable success, and refine boardroom governance strategies for a stronger future.
